Floatz logo

PREDNISONE TABLETS

Urogenital Neoplasms

Eli Lilly and CompanySmall moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Urogenital Neoplasms cohort.

Asset / SponsorPhaseRating
Fluciclovine
VA Greater Los Angeles Healthcare System
Phase 4BB
Abiraterone Acetate
Eli Lilly and Company
Phase 3B
Cyclophosphamide
Sheba Medical Center
Phase 2B
Epirubicin
Sheba Medical Center
Phase 2B
Abemaciclib
Eli Lilly and Company
Phase 3B

View all 29 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →